Elizabethkingia meningoseptica Infection in COVID-19 Patients

Mas Chaponda; Adila Shaukat; Mohammad Wajeh Dulli; Stephanie Sioufi; Walid Al Wali

doi:10.7759/cureus.30337

Elizabethkingia meningoseptica Infection in COVID-19 Patients

Cureus. 2022 Oct 15;14(10):e30337. doi: 10.7759/cureus.30337. eCollection 2022 Oct.

Authors

Mas Chaponda¹, Adila Shaukat¹, Mohammad Wajeh Dulli², Stephanie Sioufi², Walid Al Wali³

Affiliations

¹ Infectious Diseases Department, Hamad Medical Corporation, Doha, QAT.
² Internal Medicine Department, Hamad Medical Corporation, Doha, QAT.
³ Microbiology, Hamad Medical Corporation, Doha, QAT.

Abstract

Bacterial and fungal coinfections including the emergence of antimicrobial resistance are well-recognized in the era of coronavirus disease 2019 (COVID-19) infections. We present three cases of Elizabethkingia meningoseptica (EM), superinfections in COVID-19 patients admitted between the period of April 2021 and May 2021. All cases were intubated; had central venous catheters, had received prior antibiotics and antivirals as well as dexamethasone as part of severe COVID-19 management. Only one patient received anakinra. EM isolates were resistant to most available antibiotics and patients infected with it had poor treatment outcomes.

Keywords: antibiotic resistance; bacteremia; covid-19; elizabethkingia meningoseptica; healthcare associated infections; polymicrobial bacteremia; prognosis.

Publication types

Case Reports